Early identification of alcohol-related liver disease in patients with alcohol dependence is vital, both to enhance their clinical management and as a potential motivator for abstinence. 1 The current ...

SmartExam is a novel computational method compatible with FibroScan that uses a software called SmartDepth and continuous controlled attenuation parameter measurements to evaluate liver fibrosis and ...

NHA The Fibroscan device (Echosens) works by measuring shear wave velocity. In this technique, a 50-MHz wave is passed into the liver from a small transducer on the end of an ultrasound probe (Figures ...

Background Liver biopsy is considered the criterion standard for assessment of liver fibrosis and cirrhosis. However, it is not routinely performed due to its invasiveness, cost, and potential ...

3.1 Liver disease is a significant and growing cause of mortality in the UK and is often asymptomatic in early stages. Clinical experts explained that bringing FibroScan testing closer to people who ...

Methotrexate (MTX) was frequently the first-line treatment for rheumatic diseases (RDs) due to its inexpensive cost and proven effectiveness in decreasing disease activity. For a study, researchers ...

PARIS & WALTHAM, Mass.--(BUSINESS WIRE)--Echosens, a high-technology company offering the FibroScan ® family of products, is pleased to announce its strong presence at the upcoming American ...

WALTHAM, Mass. & FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Echosens North America, a high-technology company offering the FibroScan ® portfolio of solutions, and ChronWell, a digital health and ...

Echosens, the company behind the industry-leading FibroScan technology, is introducing FibroScan 630 Expert, a unique device that drives non-invasive liver disease management to the next level.

1 Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey 2 Istanbul Faculty of Medicine, Department of Internal Medicine, Division of ...